Cargando…
Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes
BACKGROUND: Impaired quality of life is common in patients with end-stage kidney disease. We report the baseline quality of life measures in participants from the PIVOTAL randomized controlled trial and the potential relationship with the primary outcome (all-cause mortality, myocardial infarction,...
Autores principales: | Bhandari, Sunil, Parfrey, Patrick, White, Claire, Anker, Stefan D., Farrington, Kenneth, Ford, Ian, Kalra, Philip A., McMurray, John J. V., Robertson, Michele, Tomson, Charles R. V., Wheeler, David C., Macdougall, Iain C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061401/ https://www.ncbi.nlm.nih.gov/pubmed/36995528 http://dx.doi.org/10.1007/s40620-023-01571-6 |
Ejemplares similares
-
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis
por: Petrie, Mark C, et al.
Publicado: (2021) -
An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
por: Thomson, Peter C., et al.
Publicado: (2022) -
Investigation into the effects of commencing haemodialysis in the critically ill
por: Docking, R, et al.
Publicado: (2012) -
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients
por: Bhandari, Sunil, et al.
Publicado: (2015) -
The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trial
por: Greenwood, Sharlene A, et al.
Publicado: (2020)